New feature! Use PharmData's unclaimed EPS scripts tool to identify unclaimed and short-dated EPS prescriptions for your pharmacy, to help streamline your dispensary processes, save money and provide a great service to your patients. Try now for free »
2019-10-16 10:24:29 (1 year(s) ago)
Aventis Pharma Limited t/a Sanofi has informed the MHRA that a change to the Patient Information Leaflet concerning possible side effects for Rifadin (rifampicin) 150mg Capsules has not been implemented by the required …